Collectively, these results suggest that NCD might exert its immunomodulatory and anti-tumor effects by targeting JAK2 and inhibiting the JAK2-STAT3 signaling pathway, thereby promoting the expression of immune-activating genes in TNBC cells. The gene discussed is STAT3; the disease is neoplasm.